Millendo Therapeutics
closedAtterocor focuses on research and development of therapeutics for adrenal disease.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD164—245m (Dealroom.co estimates Aug 2018.)
Company register number 497575621
Ann Arbor Michigan (HQ), Écully Auvergne-Rhône-Alpes (founding location)
Authorizing premium user...